Not quite to the $14.80 I was predicting by this Friday, but not bad. I expect some consolidation in ECYT before it takes another meaningful upward run. Long term, I see this company as another Celgene. I'll be adding more on any 5% to 10% pullback in price. Already have orders in at $13.49.